Delivery outcome after the use of antidepressants in early pregnancy

European Journal of Clinical Pharmacology

Volumn 55, Issue 7, 1999, Pages 503-508

  Ericson, A ^a   Kallen B ^b   Wiholm, B E ^c  

^a CENTRE FOR EPIDEMIOLOGY   (Sweden)

^b UNIVERSITY OF LUND   (Sweden)

^c MEDICAL PRODUCTS AGENCY   (Sweden)

Author keywords

Antidepressants; Pregnancy; SSRI

Indexed keywords

AMITRIPTYLINE; ANTIDEPRESSANT AGENT; CITALOPRAM; CLOMIPRAMINE; FLUOXETINE; IMIPRAMINE; LOFEPRAMINE; MAPROTILINE; MIANSERIN; MOCLOBEMIDE; NORTRIPTYLINE; PAROXETINE; SEROTONIN UPTAKE INHIBITOR; SERTRALINE; TRIMIPRAMINE; VENLAFAXINE;

ADULT; ARTICLE; BIRTH WEIGHT; CIGARETTE SMOKING; CONGENITAL MALFORMATION; DELIVERY; DEPRESSION; DRUG EFFECT; DRUG UTILIZATION; FEMALE; FIRST TRIMESTER PREGNANCY; HUMAN; MAJOR CLINICAL STUDY; MATERNAL AGE; MULTIPLE PREGNANCY; NEWBORN MORTALITY; OUTCOMES RESEARCH; PARITY; PRIORITY JOURNAL;

ADOLESCENT; ADULT; ANTIDEPRESSIVE AGENTS; BIRTH WEIGHT; EMBRYONIC AND FETAL DEVELOPMENT; FEMALE; GESTATIONAL AGE; HUMANS; INFANT MORTALITY; INFANT, NEWBORN; INFANT, NEWBORN, DISEASES; MATERNAL AGE; MIDDLE AGED; ODDS RATIO; PARITY; PREGNANCY; PREGNANCY OUTCOME; SEROTONIN UPTAKE INHIBITORS; SMOKING; TWINS;

EID: 0032883795     PISSN: 00316970     EISSN: None     Source Type: Journal    
DOI: 10.1007/s002280050664     Document Type: Article

References (13)

1. McBride WG (1972) The teratogenic effect of imipramine. Teratology 5: 262
2. Schardein JL (1985) Chemically induced birth defects. Marcel Dekker, New York, p 203
3. McElhatton PR, Garbis HM, Elefant E, et al (1996) The outcome of pregnancy in 689 women exposed to therapeutic doses of antidepressants. A collaborative study of the European Network of Teratology Information Services (ENTIS). Reprod Toxicol 10: 285-294
4. Pastuszak A, Schick-Boschetto B, Zuber C, et al (1993) Pregnancy outcome following first-trimester exposure to fluoxetine (Prozac). JAMA 269: 2246-2248
5. Kulin NA, Pastuszak A, Sage SR, et al (1998) Pregnancy outcome following maternal use of the new selective serotonin reuptake inhibitors: a prospective controlled multicenter study. JAMA 279: 609-610
6. Chambers CD, Johnson KA, Dick LM, Felix RJ, Jones KL (1996) Birth outcomes in pregnant women taking fluoxetin. N Engl J Med 335: 1010-1015
7. Goldstein DJ, Corbin LA, Sundell KL (1997) Effects of first-trimester fluoxetin exposure on the newborn. Obstet Gynecol 89: 713-718
8. Nulman I, Rovet J, Stewart DE, et al (1997) Neurodevelopment of children exposed in utero to antidepressant drugs. N Engl J Med 336: 258-262
9. Källén B (1998) Delivery outcome after the use of acid-suppressing drugs in early pregnancy with special reference to omeprazole. Br J Obstet Gynecol 105: 877-881
10. Källén B, Rydhstrom H, Åberg A (1999) Congenital malformations after the use of inhaled budesonide in early pregnancy. Obstet Gynecol 93: 392-395
11. Cnattingius S, Ericson A, Gunnarskog J, Källén B (1990) A quality study of a medical birth register. Scand J Soc Med 18: 143-145
12. Källén B (1987) Search for teratogenic risks with the aid of malformation registries. Teratology 35: 47-52
13. Goodnick PJ, Henry JH, Buki VM (1995) Treatment of depression in patients with diabetes mellitus. J Clin Psychiatry 56: 128-136